Palisade Bio, Inc.

NasdaqCM:PALI Voorraadrapport

Marktkapitalisatie: US$3.3m

Palisade Bio Beheer

Beheer criteriumcontroles 1/4

Palisade Bio's CEO is J. Finley, appointed in Apr 2021, has a tenure of 3.58 years. total yearly compensation is $1.28M, comprised of 40.7% salary and 59.3% bonuses, including company stock and options. directly owns 1.14% of the company’s shares, worth $37.32K. The average tenure of the management team and the board of directors is 2.4 years and 0.8 years respectively.

Belangrijke informatie

J. Finley

Algemeen directeur

US$1.3m

Totale compensatie

Percentage CEO-salaris40.7%
Dienstverband CEO3.6yrs
Eigendom CEO1.1%
Management gemiddelde ambtstermijn2.4yrs
Gemiddelde ambtstermijn bestuurless than a year

Recente managementupdates

Recent updates

Palisade Bio announces CEO transition

Oct 11

Palisade Bio streamlines operations, including cutting 20% of employees

Sep 15

Palisade Bio GAAP EPS of -$0.12

Aug 15

Palisade Bio begins phase 3 study testing LB1148 for postoperative return of bowel function

Jul 27

Palisade Bio rises 10% after starting phase 3 study of gastrointestinal surgery therapy

Jun 29

Palisade Bio (NASDAQ:PALI) Will Have To Spend Its Cash Wisely

Mar 28
Palisade Bio (NASDAQ:PALI) Will Have To Spend Its Cash Wisely

Palisade Bio: Guarding Intestinal Integrity

Nov 07

Analyse CEO-vergoeding

Hoe is J. Finley's beloning veranderd ten opzichte van Palisade Bio's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$14m

Mar 31 2024n/an/a

-US$14m

Dec 31 2023US$1mUS$520k

-US$12m

Sep 30 2023n/an/a

-US$13m

Jun 30 2023n/an/a

-US$14m

Mar 31 2023n/an/a

-US$13m

Dec 31 2022US$614kUS$441k

-US$15m

Sep 30 2022n/an/a

-US$9m

Jun 30 2022n/an/a

-US$358k

Mar 31 2022n/an/a

-US$27m

Dec 31 2021US$1mUS$365k

-US$27m

Sep 30 2021n/an/a

-US$32m

Jun 30 2021n/an/a

-US$39m

Mar 31 2021n/an/a

-US$12m

Dec 31 2020US$532kUS$293k

-US$10m

Compensatie versus markt: J.'s total compensation ($USD1.28M) is above average for companies of similar size in the US market ($USD655.65K).

Compensatie versus inkomsten: J.'s compensation has increased whilst the company is unprofitable.


CEO

J. Finley (67 yo)

3.6yrs

Tenure

US$1,277,100

Compensatie

Mr. J. D. Finley serves as its Chief Executive Officer of Palisade Bio, Inc. since 2023 and has been its Director since February 2023. He serves as the Chief Financial Officer at Palisade Bio, Inc. (Altern...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
J. Finley
CEO, CFO & Director3.6yrsUS$1.28m1.14%
$ 37.3k
Mitchell Jones
COO & Chief Medical Officer1.2yrsUS$738.81k0.33%
$ 10.7k
Joerg Heyer
Head of Translational Science & Medicineless than a yeargeen gegevensgeen gegevens
Ryker Willie
Senior VP of Finance & Corporate Controller6.4yrsgeen gegevensgeen gegevens

2.4yrs

Gemiddelde duur

Ervaren management: PALI's management team is considered experienced (2.4 years average tenure).


Bestuursleden

NaamPositieTenureCompensatieEigendom
J. Finley
CEO, CFO & Director1.8yrsUS$1.28m1.14%
$ 37.3k
Margery Fischbein
Independent Directorless than a yeargeen gegevensgeen gegevens
Donald Williams
Independent Chairman of the Board3.6yrsUS$87.23k0.28%
$ 9.3k
Bruce Sands
Member of Clinical Advisory Boardless than a yeargeen gegevensgeen gegevens
Florian Rieder
Member of Clinical Advisory Boardless than a yeargeen gegevensgeen gegevens

0.8yrs

Gemiddelde duur

67yo

Gemiddelde leeftijd

Ervaren bestuur: PALI's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.